An Open Label SLV308 Safety Extension to Study S308.3.002 in Patients With Parkinson's Disease Experiencing Motor Fluctuations.

NCT00407095 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

140

Enrollment

INDUSTRY

Sponsor class

Conditions

Advanced Stage Parkinson's Disease

Interventions

DRUG: Pardoprunox

Sponsor

Solvay Pharmaceuticals